Isabel Ohs

854 total citations
6 papers, 673 citations indexed

About

Isabel Ohs is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, Isabel Ohs has authored 6 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Oncology and 2 papers in Surgery. Recurrent topics in Isabel Ohs's work include Immune Cell Function and Interaction (5 papers), IL-33, ST2, and ILC Pathways (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Isabel Ohs is often cited by papers focused on Immune Cell Function and Interaction (5 papers), IL-33, ST2, and ILC Pathways (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Isabel Ohs collaborates with scholars based in Switzerland, Germany and United Kingdom. Isabel Ohs's co-authors include Burkhard Becher, Sònia Tugues, Kathrin Nussbaum, Paulina Kulig, Sara Burkhard, Johannes vom Berg, Melissa Vrohlings, Sebastian J. Arnold, Florian Mair and Christoph S. N. Klose and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Cancer Research.

In The Last Decade

Isabel Ohs

6 papers receiving 669 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabel Ohs Switzerland 6 465 332 151 85 69 6 673
Sara Burkhard Switzerland 5 386 0.8× 238 0.7× 137 0.9× 80 0.9× 63 0.9× 7 552
Xiaoxia Tan United States 11 308 0.7× 357 1.1× 136 0.9× 29 0.3× 68 1.0× 17 583
Heba Nowyhed United States 12 670 1.4× 274 0.8× 179 1.2× 59 0.7× 37 0.5× 17 867
Romain Vuillefroy de Silly Switzerland 13 449 1.0× 236 0.7× 122 0.8× 36 0.4× 52 0.8× 15 635
Margaux Vienne France 7 773 1.7× 417 1.3× 191 1.3× 122 1.4× 31 0.4× 9 985
Perpetua U. Emeagi Belgium 8 314 0.7× 302 0.9× 217 1.4× 28 0.3× 63 0.9× 9 559
Andreas Bonertz Germany 12 599 1.3× 443 1.3× 163 1.1× 86 1.0× 31 0.4× 24 883
Bhalchandra Mirlekar United States 11 643 1.4× 458 1.4× 278 1.8× 34 0.4× 51 0.7× 15 973
Amy-Jo Casbon United States 9 515 1.1× 367 1.1× 243 1.6× 37 0.4× 25 0.4× 11 835
Sabina Kaczanowska United States 8 524 1.1× 361 1.1× 319 2.1× 32 0.4× 51 0.7× 11 870

Countries citing papers authored by Isabel Ohs

Since Specialization
Citations

This map shows the geographic impact of Isabel Ohs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Ohs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Ohs more than expected).

Fields of papers citing papers by Isabel Ohs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Ohs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Ohs. The network helps show where Isabel Ohs may publish in the future.

Co-authorship network of co-authors of Isabel Ohs

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Ohs. A scholar is included among the top collaborators of Isabel Ohs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Ohs. Isabel Ohs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Beffinger, Michał, Paulino Tallón de Lara, Sònia Tugues, et al.. (2018). CSF1R-dependent myeloid cells are required for NK‑mediated control of metastasis. JCI Insight. 3(10). 37 indexed citations
2.
Ohs, Isabel, et al.. (2017). Restoration of Natural Killer Cell Antimetastatic Activity by IL12 and Checkpoint Blockade. Cancer Research. 77(24). 7059–7071. 66 indexed citations
3.
Nussbaum, Kathrin, Sara Burkhard, Isabel Ohs, et al.. (2017). Tissue microenvironment dictates the fate and tumor-suppressive function of type 3 ILCs. The Journal of Experimental Medicine. 214(8). 2331–2347. 79 indexed citations
4.
Ohs, Isabel, Maries van den Broek, Kathrin Nussbaum, et al.. (2016). Interleukin-12 bypasses common gamma-chain signalling in emergency natural killer cell lymphopoiesis. Nature Communications. 7(1). 13708–13708. 26 indexed citations
5.
Christiansen, Ailsa J., Lothar C. Dieterich, Isabel Ohs, et al.. (2016). Lymphatic endothelial cells attenuate inflammation via suppression of dendritic cell maturation. Oncotarget. 7(26). 39421–39435. 50 indexed citations
6.
Tugues, Sònia, Sara Burkhard, Isabel Ohs, et al.. (2014). New insights into IL-12-mediated tumor suppression. Cell Death and Differentiation. 22(2). 237–246. 415 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026